Navigation Links
Interventional Pulmonology Creeping into Bronchoscopy Market

Interventional Pulmonology is expected to increase the bronchoscopy market to approximately $180 million in 2012, according to Millennium Research


WALTHAM, Mass., April 7, 2008 /PRNewswire/ -- According to Millennium Research Group's US Markets for ENT & Bronchoscopy 2008 report, an emerging field -- interventional pulmonology -- is creeping into the bronchoscopy market, and is expected to grow the overall market to $180 million by 2012.

To date, the majority of bronchoscopy procedures have been performed to diagnose pulmonary conditions such as lung cancer and chronic lung disease. A number of medical devices that can be used to treat lung-related conditions are, however, awaiting FDA approval. If these therapeutic devices are approved, bronchoscopy procedure volumes in the US will expand as pulmonologists and thoracic surgeons gain the ability to both diagnose and treat lung-related conditions using minimally invasive techniques. Because many interventional pulmonology procedures will be performed with a flexible bronchoscope, therapeutic device approval will also fuel demand for flexible bronchoscopes and other conventional bronchoscopy devices.

Asthmatx' Alair System, which was developed to treat severe asthma cases, will be submitted for FDA premarket approval in 2008. Its approval will add bronchial thermoplasty to the list of treatments that can be performed with flexible bronchoscopy.

"To date, clinical studies performed with the system have showed favorable results," says Tiffanie Demone, Analyst at Millennium Research Group. "A study published in the New England Journal of Medicine in March 2007 found that patients who underwent a bronchial thermoplasty used less rescue medication such as that found in inhalers and showed improvements to their quality of life. Moreover, there were almost 2.5 million severe asthma patients in the US in 2007 who could potentially benefit from bronchial thermoplasty."

The US Markets for ENT & Bronchoscopy 2008 report provides coverage of key industry competitors, including Arthrocare, Boston Scientific, Medtronic, and Olympus.

About Interventional Pulmonology

Interventional pulmonology is the treatment of breathing-related disorders such as asthma, lung cancer, chronic obstructive pulmonary disease, and emphysema. Paralleling the interventional cardiology market in the 1980s, the development of interventional pulmonology is changing the role of a pulmonologist from diagnostician to therapeutic interventionalist. A number of interventional pulmonology device developers formed over the last few years, including Emphasys Medical, Asthmatx, Spiration, Pulmonx, PneumRx, and superDimension. The approval and adoption of medical devices developed by these companies will expand the interventional pulmonology market in the coming years.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC
2. Safe at Any Age: Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures
3. New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants
4. Register Now for Interventional Radiology Meeting Press Conferences
5. SCAI Announces New Program to Support Interventional Cardiology Training Fellowships
6. Siemens Introduces Its New Generation of Artis Interventional Imaging Systems
7. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
8. Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists
9. SCAI and ACC announce new interventional cardiology meeting
10. Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
11. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Post Your Comments:
(Date:10/13/2017)... N.Y (PRWEB) , ... October 13, 2017 , ... Lori ... became a member of ElderCounsel, a national organization of elder law and special needs ... changing laws and rules. It also provides a forum to network with elder law ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: